Who should attend
About BA BE study
This short orientation training provides fundamental understanding and requirements for conducting Bioavailability and Bioequivalence BA BE Study. Bioequivalence is a term in pharmacokinetics used to assess the expected in vivo biological equivalence of generic version to its proprietary version of a drug or formulations of innovator drug in different clinical trial phases. Here in this online course we carry out the design and analysis of bioavailability and bioequivalence studies.
It is important for pharmaceutical manufacturer to establish Bioavailability and Bioequivalence BA BE Study in compliance with current regulations is therefore critical to development of generic pharmaceutical products. Therefore, BA / BE guideline need to be followed as specified by the regulatory agency. And stability results should be incorporated in the drug dossier which in turn submitted to regulatory agency.
In this online self-paced modules, participant will be understanding about the requirement of the Bioavailability and Bioequivalence BA BE Study The course provide valuable insight on Bioavailability and Bioequivalence guidelines and how to conduct the BA BE study.
Course Code: RYD-094
Course Title: Fundamental Training in Bioavailability Bioequivalence (BA/BE) Study [Microlearning Course]
Online micro learning course. So, course can be accessed online across anywhere 24×7.
Duration: 3 Days
Any body who wants to acquire detailed understanding on BA and BE study, should attend the course.
Any body who wants to acquire competency regarding new drug development process, should attend the course.
Who should attend this course?
- This course is ideal for those who requires detailed BA BE study understanding. For example, those working in Analytical Development, Analytical Chemistry, Stability Testing, Formulation Development, Regulatory Affairs, Pharmaceutical & Biopharmaceutical Production, Product Development, Technical Operations.
- Fresher/Beginners, Those who want to make a career in drug regulatory or pharmaceutical products.
- Moreover, this Bioavailability and Bioequivalence study will be ideal for BA/BE managers, R&D managers, Pharmacokinetics scientists, IVIVC specialists, Formulation managers, Solid dosage formulators, Regulatory affairs managers.
Certificate will be provided at the end of the successful completion of the course
- This course provides detailed understanding on Bioavailability and Bioequivalence (BA / BE) studies which need to be adopted by the pharmaceutical producers. Hence, this course is ideal for the regulatory, QA/QC professions, or those who are handling drug dossier for regulatory submission.
- The course focus on how to design a bioequivalence study.
- Moreover, course also provide clear cut understanding of the statistical design needed to get regulatory approval.
- Most importantly, course connects the understanding of the dissolution data to pharmacokinetics, and the predictive power of the pilot studies.
- The requirements for studies in fasting and fed state
- Validation and compliance issues
- What is the relationship between formulation and bioavailability?
- What to look for when auditing a BA BE study house in terms of validation.
- Insight on IVIVC.
Few of the similar courses
BA/BE studies is the short form of Bioavailability & Bioequivalence Studies. Bioequivalence is a term in pharmacokinetics. Bioequivalence assess the expected in vivo biological equivalence of generic version to its proprietary version of a drug or formulations of innovator drug in different clinical trial phases.
The study evaluates clinical differences in the bioavailability of two distinct drugs. These studies are conducted to assess the efficacy of a new drug product which may have a few different excipients or inactive ingredients.
Differences between BA and BE study
Bioavailability studies (BA studies) focus on determining the process and time frame by which a drug substance is released from the oral dosage form and moves to the site of action. On the other hand, bioequivalence studies focus on the performance of the drug product. BA and BE study usually involve comparisons of two drug products.
A pharmacokinetic (PK) study of a new drug involves taking several blood samples over a period of time from study participants to determine how the body handles the substance. These studies provide critical information about new drugs.